الفهرس 
cover englishOnly 14 pages are availabe for public view
 |  | from | 161 |  |  |
| | | from | 161 | | |
Abstract
Aim Of Work. The Purpose Of Our Study Was To Evaluate The Perioperative Complications, Toxicity, Mortality Rates After Cytoreductive Surgery (CRS), And Effects Of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Used In The Treatment Of Peritoneal Surface Malignancies. At A Single Institution” National Cancer Institution” In Egypt. Methods. Between June 2010 And December 2014, We Performed 51 CRS And HIPEC With The Closed Abdominal Technique For Patients With Peritoneal Carcinomatosis (PC) from Different Primary Tumors. Systemic Toxicities Were Graded According To The National Cancer Institute (NCI) Common Terminology Criteria For Adverse Events (CTCAE) Version 3.0 Criteria Andclavien-Dindo Classification For Surgical Complications And Were Analyzed from A Prospectively Collected Database. Results. Total Of 51 Procedures Of CRS And HIPEC Were Performed On Patients With, Peritoneal Carcinomatosis (PC) from Different Primary Cancer. The Morbidity Rate Was 39.2% Of All Procedure, And Grades I/II And Grades III/IV Complications Were 19.2% And 19.2%, Respectivelyaccording Common Terminology Criteria For Adverse Events (CTCAE). The Most Frequent Complication Was Intestinal Leakage Including Intestinal Fistula 35% (7/20) Of Total Number Of Postoperative Complications. The Mortality Rate Was 5.8%, And Reoperation Was Needed In 3.9 % Of All Procedures (2/51).Mortalities Were In Cases Of Anastomotic Leakage Were Required Reoperation , First Patient, To Do Ileostomy And Burst.